Drug: VFEND Injury: Hepatic function abnormal Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
124120164 | VFEND | Hepatic function abnormal | PFIZER | 67.00 YR | F | 55 KG | 20160831 | JP |
125606861 | VFEND | Hepatic function abnormal | TAKEDA | 67.39 YR | F | 55 KG | 20160715 | JP |
125612774 | VFEND | Hepatic function abnormal | ABBVIE | 67.39 YR | F | 55 KG | 20160901 | JP |
125683212 | VFEND | Hepatic function abnormal | ASTRAZENECA | 24613.00 DY | F | 55 KG | 20160825 | JP |
127050701 | VFEND | Hepatic function abnormal | ASTRAZENECA | 61.00 YR | F | 0 | 20160831 | FR |
Total Records: 5 Number of Pages: 1